| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |